Rose Mougnutou

Effectiveness and safety of a generic fixed-dose combination of nevirapine, stavudine, and lamivudine in HIV-1-infected adults in Cameroon: open-label multicentre trial

Christian Laurent, Charles Kouanfack, Sinata Koulla‐Shiro et al. · The Lancet · 2004 · 305 citations · Full text

Pharmacy, Pharmacotherapy, Clinical Pharmacology +13

Biological and genetic characteristics of HIV infections in Cameroon reveals dual group M and O infections and a correlation between SI-inducing phenotype of the predominant CRF02_AG variant and disease stage

Laurence Vergne, Anke Bourgeois, Eitel Mpoudi‐Ngolé et al. · Virology · 2003 · 97 citations

Veterinary Medicine, Infectious Diseases, Molecular Genetics +13

No Difference in Clinical Progression between Patients Infected with the Predominant Human Immunodeficiency Virus Type 1 Circulating Recombinant Form (CRF) 02_AG Strain and Patients Not Infected with CRF02_AG, in Western and West‐Central Africa: A Four‐Year Prospective Multicenter Study

Christian Laurent, Anke Bourgeois, Mame Awa Faye et al. · The Journal of Infectious Diseases · 2002 · 57 citations · Full text

Life Sciences, Immunology, Infectious Diseases +11

Field Assessment of Generic Antiretroviral Drugs: A Prospective Cohort Study in Cameroon

Anke Bourgeois, Christian Laurent, Rose Mougnutou et al. · Antiviral Therapy · 2005 · 46 citations · Full text

Life Sciences, Infectious Diseases, Pharmacotherapy +17

Tolerability and Effectiveness of First-Line Regimens Combining Nevirapine and Lamivudine Plus Zidovudine or Stavudine in Cameroon

Christian Laurent, Anke Bourgeois, Eitel Mpoudi‐Ngolé et al. · AIDS Research and Human Retroviruses · 2008 · 40 citations

Pharmacy, Pharmacology, Pharmacotherapy +17